Fishman Jay A Ltd. MI Invests $1.47 Million in Encompass Health Corporation $EHC

Fishman Jay A Ltd. MI acquired a new position in shares of Encompass Health Corporation (NYSE:EHC) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 13,830 shares of the company’s stock, valued at approximately $1,468,000.

Other hedge funds have also added to or reduced their stakes in the company. Citizens National Bank Trust Department acquired a new stake in Encompass Health during the 3rd quarter worth $26,000. First Horizon Corp acquired a new stake in Encompass Health during the 3rd quarter worth $34,000. Westside Investment Management Inc. raised its stake in Encompass Health by 56.7% during the 3rd quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after buying an additional 101 shares during the period. Assetmark Inc. raised its stake in Encompass Health by 88.1% during the 3rd quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after buying an additional 140 shares during the period. Finally, Root Financial Partners LLC bought a new position in Encompass Health during the 3rd quarter worth about $39,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Insider Activity at Encompass Health

In related news, CEO Mark J. Tarr sold 150,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total value of $16,746,000.00. Following the completion of the sale, the chief executive officer directly owned 377,070 shares in the company, valued at approximately $42,096,094.80. The trade was a 28.46% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Treasurer Edmund Fay sold 11,937 shares of the business’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the sale, the treasurer owned 89,325 shares of the company’s stock, valued at approximately $9,557,775. This trade represents a 11.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 1.80% of the company’s stock.

Analyst Upgrades and Downgrades

EHC has been the subject of several recent research reports. Wall Street Zen cut Encompass Health from a “buy” rating to a “hold” rating in a research report on Saturday, April 11th. Barclays lifted their price target on Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a report on Friday, February 6th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Encompass Health presently has a consensus rating of “Buy” and an average price target of $143.29.

Encompass Health Trading Down 0.4%

Shares of NYSE:EHC opened at $102.31 on Thursday. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99. The stock has a market cap of $10.17 billion, a PE ratio of 18.47, a P/E/G ratio of 1.97 and a beta of 0.75. The business has a 50 day moving average of $104.02 and a 200-day moving average of $108.47. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 5th. The company reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. The company had revenue of $3.09 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The business’s revenue was up 9.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.17 earnings per share. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. As a group, equities research analysts forecast that Encompass Health Corporation will post 5.91 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st were paid a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Wednesday, April 1st. Encompass Health’s payout ratio is 13.72%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.